Sign In
Buy HBIO
$6.50
+0.0400 (+0.619%)
At Close: Jun 03, 2026
Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024
04:05pm, Thursday, 06'th Jun 2024
HOLLISTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Off
Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
04:05pm, Thursday, 23'rd May 2024
HOLLISTON, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Offi
Electric school buses may yield significant health and climate benefits, cost savings
03:00pm, Monday, 20'th May 2024
Replacing diesel school buses with electric school buses may yield up to $247,600 in climate and health benefits per individual bus, according to a new study by researchers at Harvard T.H. Chan School
Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference
04:05pm, Thursday, 16'th May 2024
HOLLISTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Offi
Harvard Bioscience, Inc. (HBIO) Q1 2024 Earnings Call Transcript
12:52pm, Tuesday, 07'th May 2024
Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q1 2024 Earnings Conference Call May 7, 2024 8:00 AM ET Company Participants Dave Sirois - Director, SEC Reporting Jim Green - Chairman, President and CEO Jenni
Harvard Bioscience (HBIO) Q1 Earnings Match Estimates
09:16am, Tuesday, 07'th May 2024
Harvard Bioscience (HBIO) came out with quarterly earnings of $0.02 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.06 per share a year ago.
Harvard Bioscience Announces First Quarter 2024 Financial Results
07:00am, Tuesday, 07'th May 2024
Strong gross margin performance and focus on efficiency to support ongoing investments in growth Strong gross margin performance and focus on efficiency to support ongoing investments in growth
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
08:45am, Monday, 29'th Apr 2024
HOLLISTON, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2024 before the market opens on May 7,
Watch These 5 Technology Stocks for Q1 Earnings: Beat or Miss?
12:46pm, Monday, 22'nd Apr 2024
Here is a sneak peek into how five technology stocks, MANH, MSCI, AEYE, HBIO and TXN, are expected to fare in their quarterly results slated to be released on Apr 23.
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
09:00am, Tuesday, 09'th Apr 2024
HOLLISTON, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced a labor force reduction to improve its operating cost structure and support its ongoing inv
HOLLISTON, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, will be presenting to investors at th
Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Call Transcript
09:56am, Thursday, 07'th Mar 2024
Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q4 2023 Earnings Conference Call March 7, 2024 8:00 AM ET Company Participants Dave Sirois - Director, SEC Reporting Jim Green - Chairman, President & Chief Exe
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
07:00am, Thursday, 07'th Mar 2024
HOLLISTON, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the fourth quarter and year ended December 31, 20
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
08:30am, Wednesday, 06'th Mar 2024
Solutions for CROs, pharma and biotechs improve throughput and efficiency and enable future advancements in data analytics Solutions for CROs, pharma and biotechs improve throughput and efficiency and
Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
05:10pm, Tuesday, 27'th Feb 2024
HOLLISTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended December 31, 2023 before the market opens on March
